LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Search

Teleflex Inc

Geschlossen

BrancheGesundheitswesen

109.25 0.69

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

108.07

Max

109.69

Schlüsselkennzahlen

By Trading Economics

Einkommen

28M

123M

Verkäufe

80M

781M

KGV

Branchendurchschnitt

28.636

77.256

Dividendenrendite

1.09

Gewinnspanne

15.697

Angestellte

14,100

EBITDA

128M

223M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+25.69% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.09%

2.33%

Nächste Dividendenausschüttung

15. Dez. 2025

Nächstes Ex-Dividendendatum

14. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

323M

5.4B

Vorheriger Eröffnungskurs

108.56

Vorheriger Schlusskurs

109.25

Nachrichtenstimmung

By Acuity

44%

56%

142 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Teleflex Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Nov. 2025, 21:36 UTC

Ergebnisse

Australia's ANZ Bank Posts 10% Drop in Annual Profit -- Update

9. Nov. 2025, 21:22 UTC

Ergebnisse

Australia's ANZ Bank Posts 10% Drop in Annual Profit

10. Nov. 2025, 00:00 UTC

Market Talk

India Inflation Poised to Hit New Low -- Market Talk

9. Nov. 2025, 23:47 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

9. Nov. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Signs of U.S. Economic Weakness -- Market Talk

9. Nov. 2025, 21:05 UTC

Ergebnisse

ANZ FY Total Operating Expenses A$12.88B Vs. A$11.465B Pro Forma>ANZ.AU

9. Nov. 2025, 21:04 UTC

Ergebnisse

ANZ FY Operating Expenses A$11.85B Ex-Significant Items>ANZ.AU

9. Nov. 2025, 21:03 UTC

Ergebnisse

ANZ 2H Net Interest Margin 1.54% Vs. 1.56% in 1H>ANZ.AU

9. Nov. 2025, 20:49 UTC

Ergebnisse

ANZ FY Australia Retail Deposits Up 6% on Year>ANZ.AU

9. Nov. 2025, 20:49 UTC

Ergebnisse

ANZ FY Australia Home Loan Lending Up 5% on Year>ANZ.AU

9. Nov. 2025, 20:45 UTC

Ergebnisse

ANZ FY Average Customer Deposits A$760.8B Vs. A$669.4B>ANZ.AU

9. Nov. 2025, 20:45 UTC

Ergebnisse

ANZ FY Average Gross Loans & Advances A$833.6B Vs. A$733.8B>ANZ.AU

9. Nov. 2025, 20:42 UTC

Ergebnisse

ANZ FY Results Include Full-Year Benefit of Suncorp Bank Acquisition>ANZ.AU

9. Nov. 2025, 20:42 UTC

Ergebnisse

ANZ FY Net Interest Margin 1.55% Vs. 1.57%>ANZ.AU

9. Nov. 2025, 20:41 UTC

Ergebnisse

ANZ FY Common Equity Tier 1 Ratio 12.0% Vs. 12.2%>ANZ.AU

9. Nov. 2025, 20:41 UTC

Ergebnisse

ANZ FY Net Profit Includes A$1.11B of Notable Items>ANZ.AU

9. Nov. 2025, 20:39 UTC

Ergebnisse

ANZ FY Credit Impairment Charge A$441M Vs. A$406M>ANZ.AU

9. Nov. 2025, 20:39 UTC

Ergebnisse

ANZ FY Rev A$22.19B Vs. A$20.55B >ANZ.AU

9. Nov. 2025, 20:38 UTC

Ergebnisse

ANZ Keeps Dividend at A$0.83 >ANZ.AU

9. Nov. 2025, 20:38 UTC

Ergebnisse

ANZ FY Cash Profit A$5.79B Vs. A$6.725B>ANZ.AU

9. Nov. 2025, 20:38 UTC

Ergebnisse

ANZ FY Net A$5.89B Vs. Net A$6.535B >ANZ.AU

8. Nov. 2025, 13:10 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8. Nov. 2025, 03:50 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8. Nov. 2025, 03:41 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8. Nov. 2025, 03:07 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7. Nov. 2025, 22:36 UTC

Ergebnisse

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7. Nov. 2025, 22:22 UTC

Ergebnisse

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7. Nov. 2025, 22:03 UTC

Ergebnisse

Constellation Software 3Q Rev $2.95B >CSU.T

7. Nov. 2025, 22:03 UTC

Ergebnisse

Constellation Software 3Q Net $210M >CSU.T

7. Nov. 2025, 22:03 UTC

Ergebnisse

Constellation Software 3Q EPS $9.89 >CSU.T

Peer-Vergleich

Kursveränderung

Teleflex Inc Prognose

Kursziel

By TipRanks

25.69% Vorteil

12-Monats-Prognose

Durchschnitt 137.5 USD  25.69%

Hoch 155 USD

Tief 120 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Teleflex Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

1

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

122.73 / 135.75Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

142 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat